Exact Mass: 317.1159

Exact Mass Matches: 317.1159

Found 73 metabolites which its exact mass value is equals to given mass value 317.1159, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

N-(1-Deoxy-1-fructosyl)histidine

(2S)-3-(1H-imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methyl}amino)propanoic acid

C12H19N3O7 (317.1223)


Fructose aminoacids are naturally occurring compounds derived from D-fructose and L-aminoacids. They are amadori products resulting from sugar-aminoacid interactions in food products, especially cooked foods [CCD] N-(1-Deoxy-1-fructosyl)histidine is classified as a Natural Food Constituent (code WA) in the DFC.

   

Tsitsikammamine B

Tsitsikammamine B

C19H15N3O2 (317.1164)


   

8,13,13b,14-Tetrahydro-14-formylindolo[2,3:3,4]pyrido[2,1-b]quinazoline-5(7H)-one

8,13,13b,14-Tetrahydro-14-formylindolo[2,3:3,4]pyrido[2,1-b]quinazoline-5(7H)-one

C19H15N3O2 (317.1164)


   
   

2-Methoxyruteacaprine

2-Methoxyruteacaprine

C19H15N3O2 (317.1164)


   
   
   

N,1,2,5-Tetra-Ac-beta-D-Furnose-3-Amino-3-deoxyribose

N,1,2,5-Tetra-Ac-beta-D-Furnose-3-Amino-3-deoxyribose

C13H19NO8 (317.1111)


   

Pauridianthinol

Pauridianthinol

C19H15N3O2 (317.1164)


   
   

(R)-N-(2-phenethyl)-2-(1-acetamidoethyl)thiazole-4-carboxamide|(R)-neobacillamide A|2-[(1R)-1-(acetylamino)ethyl]-N-(2-phenylethyl)-1,3-thiazole-4-carboxamide|Neobacillamide A

(R)-N-(2-phenethyl)-2-(1-acetamidoethyl)thiazole-4-carboxamide|(R)-neobacillamide A|2-[(1R)-1-(acetylamino)ethyl]-N-(2-phenylethyl)-1,3-thiazole-4-carboxamide|Neobacillamide A

C16H19N3O2S (317.1198)


   

mycosporine-glu

mycosporine-glu

C13H19NO8 (317.1111)


   
   
   
   
   

14-Formyldihydrorutaecarpine

14-Formyldihydrorutaecarpine

C19H15N3O2 (317.1164)


   

Tsitsikammamine A N-oxime / B

Tsitsikammamine A N-oxime / B

C19H15N3O2 (317.1164)


   
   
   

2,3-dihydroxybutanedioic acid,3-[1-hydroxy-2-(methylamino)ethyl]phenol

2,3-dihydroxybutanedioic acid,3-[1-hydroxy-2-(methylamino)ethyl]phenol

C13H19NO8 (317.1111)


   

Synephrine tartrate

Synephrine tartrate

C13H19NO8 (317.1111)


   

Metaraminol bitartrate

Metaraminol bitartrate

C13H19NO8 (317.1111)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents

   

(R)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

(R)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.1063)


   

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(2-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.1063)


   

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(3-FLUOROPHENYL)PROPANOIC ACID

(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(3-FLUOROPHENYL)PROPANOIC ACID

C17H16FNO4 (317.1063)


   

7-METHOXY-2,3-DIHYDRO-BENZOFURAN-3-YLAMINEHYDROCHLORIDE

7-METHOXY-2,3-DIHYDRO-BENZOFURAN-3-YLAMINEHYDROCHLORIDE

C18H20ClNO2 (317.1182)


   

Z-4-Fluoro-Phe-OH

Z-4-Fluoro-Phe-OH

C17H16FNO4 (317.1063)


   

(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)(THIAZOL-2-YL)METHANOL

(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)(THIAZOL-2-YL)METHANOL

C16H20BNO3S (317.1257)


   

Phenylephrine tartrate

(-)-Phenylephrine hydrogentartrate

C13H19NO8 (317.1111)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist

   

1-benzhydrylazetidin-3-yl Methanesulfonate

1-benzhydrylazetidin-3-yl Methanesulfonate

C17H19NO3S (317.1086)


   

N-Methyl-2,2-iminodi(8-quinolinol)

N-Methyl-2,2-iminodi(8-quinolinol)

C19H15N3O2 (317.1164)


   

RS 127445

RS 127445

C17H17ClFN3 (317.1095)


RS-127445 hydrochloride is a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist with a pKi of 9.5. RS-127445 hydrochloride shows 1000 fold selectivity for this receptor as compared to numerous other receptor and ion channel binding sites[1].

   

ETHYL 2-((4-(BENZYLOXY)-3-FLUOROPHENYL)AMINO)-2-OXOACETATE

ETHYL 2-((4-(BENZYLOXY)-3-FLUOROPHENYL)AMINO)-2-OXOACETATE

C17H16FNO4 (317.1063)


   

Pridopidine hydrochloride

4-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE, HYDROCHLORIDE

C15H24ClNO2S (317.1216)


C78272 - Agent Affecting Nervous System

   

(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl-2-propenal

(E)-3-[2-Cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl-2-propenal

C21H16FNO (317.1216)


   

ethyl 2-piperazine-4-phenyl thiazole-5-carboxylate

ethyl 2-piperazine-4-phenyl thiazole-5-carboxylate

C16H19N3O2S (317.1198)


   

tri-n-butylcyanotin

tri-n-butylcyanotin

C13H27NSn (317.1165)


   
   
   

N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride

N-Methyl-N-((3R,4R)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine dihydrochloride

C13H21Cl2N5 (317.1174)


   

(S)-7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

(S)-7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C16H16FN3O3 (317.1176)


   

(R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

(R)-2-(2,5-difluorophenyl)pyrrolidine (R)-2-hydroxysuccinate

C14H17F2NO5 (317.1075)


   

2,2,2-trifluoro-N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]acetamide

2,2,2-trifluoro-N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-yl]acetamide

C12H15BF3N3O3 (317.1159)


   

3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine

3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine

C18H20ClNO2 (317.1182)


SKF83959 is a potent and selective dopamine D1-like receptor partial agonist. SKF83959 Ki values for rat D1, D5, D2 and D3 receptors are 1.18, 7.56, 920 and 399 nM, respectively. SKF83959 is a potent allosteric modulator of sigma (σ)-1 receptor. SKF83959 belongs to benzazepine family and has improvements on cognitive dysfunction. SKF83959 can be used for the research of Alzheimer's disease and depression[1][2][3][4].

   

N-(2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-yl)benzenesulfonamide

N-(2,2,4-trimethyl-2,3-dihydro-1-benzofuran-7-yl)benzenesulfonamide

C17H19NO3S (317.1086)


   

5-({[(Isopropylamino)carbonyl]oxy}ethanimidoyl)-4-methyl-2-phenyl-1,3-thiazole

5-({[(Isopropylamino)carbonyl]oxy}ethanimidoyl)-4-methyl-2-phenyl-1,3-thiazole

C16H19N3O2S (317.1198)


   

2-(3-Formyl-2,5-dimethyl-1-pyrrolyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

2-(3-Formyl-2,5-dimethyl-1-pyrrolyl)-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid methyl ester

C17H19NO3S (317.1086)


   
   

3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol dihydrogen (2R,3R)-2,3-dihydroxybutanedioate

3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol dihydrogen (2R,3R)-2,3-dihydroxybutanedioate

C13H19NO8 (317.1111)


   
   
   
   
   
   

(1S)-14-oxo-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

(1S)-14-oxo-3,13,21-triazapentacyclo[11.8.0.02,10.04,9.015,20]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

C19H15N3O2 (317.1164)


   

N-(1-Deoxy-1-fructosyl)histidine

N-(1-Deoxy-1-fructosyl)histidine

C12H19N3O7 (317.1223)


   
   

14-fomyldihydroxyrutaecarpine

NA

C19H15N3O2 (317.1164)


{"Ingredient_id": "HBIN001457","Ingredient_name": "14-fomyldihydroxyrutaecarpine","Alias": "NA","Ingredient_formula": "C19H15N3O2","Ingredient_Smile": "C1CN2C(C3=C1C4=CC=CC=C4N3)N(C5=CC=CC=C5C2=O)C=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30970","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

acalyphine

NA

C13H19NO8 (317.1111)


{"Ingredient_id": "HBIN014320","Ingredient_name": "acalyphine","Alias": "NA","Ingredient_formula": "C13H19NO8","Ingredient_Smile": "CN1C=C(C(=CC1=O)OC)OC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "23592","TCMSP_id": "NA","TCM_ID_id": "7249","PubChem_id": "NA","DrugBank_id": "NA"}

   

18-hydroxy-5,9,9-trimethyl-4,8,17-triazapentacyclo[10.6.1.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]nonadeca-1,3,5,10,12,14,16(19),17-octaen-7-one

18-hydroxy-5,9,9-trimethyl-4,8,17-triazapentacyclo[10.6.1.0²,¹⁰.0³,⁸.0¹⁶,¹⁹]nonadeca-1,3,5,10,12,14,16(19),17-octaen-7-one

C19H15N3O2 (317.1164)


   

3-(4-hydroxyphenyl)-9-methyl-5,9,14-triazatetracyclo[6.6.1.0²,⁶.0¹¹,¹⁵]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one

3-(4-hydroxyphenyl)-9-methyl-5,9,14-triazatetracyclo[6.6.1.0²,⁶.0¹¹,¹⁵]pentadeca-1(14),2(6),3,8(15),10-pentaen-7-one

C19H15N3O2 (317.1164)


   

6-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

6-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C19H15N3O2 (317.1164)


   

18-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

18-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C19H15N3O2 (317.1164)


   

2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

2-{[5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

C13H19NO8 (317.1111)


   

7-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

7-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C19H15N3O2 (317.1164)


   

2-[(1r)-1-[(1-hydroxyethylidene)amino]ethyl]-n-(2-phenylethyl)-1,3-thiazole-4-carboximidic acid

2-[(1r)-1-[(1-hydroxyethylidene)amino]ethyl]-n-(2-phenylethyl)-1,3-thiazole-4-carboximidic acid

C16H19N3O2S (317.1198)


   

(1s)-14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

(1s)-14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

C19H15N3O2 (317.1164)


   

n-(2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)ethanimidic acid

n-(2-{12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl}ethyl)ethanimidic acid

C19H15N3O2 (317.1164)


   

19-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

19-methoxy-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(10),4,6,8,15,17,19-octaen-14-one

C19H15N3O2 (317.1164)


   

(2s)-2-{[(5r)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

(2s)-2-{[(5r)-5-hydroxy-5-(hydroxymethyl)-2-methoxy-3-oxocyclohex-1-en-1-yl]amino}pentanedioic acid

C13H19NO8 (317.1111)


   

2-{1-[(1-hydroxyethylidene)amino]ethyl}-n-(2-phenylethyl)-1,3-thiazole-4-carboximidic acid

2-{1-[(1-hydroxyethylidene)amino]ethyl}-n-(2-phenylethyl)-1,3-thiazole-4-carboximidic acid

C16H19N3O2S (317.1198)


   

14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

14-oxo-3,13,21-triazapentacyclo[11.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-2(10),4,6,8,15,17,19-heptaene-21-carbaldehyde

C19H15N3O2 (317.1164)